Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

If You Invested $1,000 In Johnson & Johnson Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now

Stock Markets Aug 18, 2022 00:40
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. If You Invested $1,000 In Johnson & Johnson Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now
 
JNJ
-0.46%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than others since the pandemic bottom.

Johnson & Johnson's Bumpy Road: One company that has been a solid investment in the past two years has been pharmaceutical giant Johnson & Johnson (NYSE: JNJ (NYSE:JNJ)).

Johnson & Johnson investors have likely been somewhat disappointed with the performance of the stock in the past two years given how much attention the company’s COVID-19 vaccine initially received.

In addition, the company is facing a number of costly and potentially damaging legal battles. In October 2020, Johnson & Johnson agreed to settle more than 1,000 talcum powder lawsuits for $100 million. That same month, the company also agreed to add an additional $1 billion to its 2019 $4 billion settlement related to its role in the U.S. opioid crisis.

At the beginning of 2020, Johnson & Johnson shares were trading at around $146. By the beginning of March, the stock was down to $134.78, after news of COVID-19 spreading in China prompted concerns about a U.S. pandemic.

Johnson & Johnson bottomed at $105.63 during the pandemic-driven March sell-off. Fortunately for J&J investors, the dip did not last long.

Related Link: If You Invested $1,000 In Southwest Airlines (NYSE:LUV) Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now

By late April, Johnson & Johnson shares were back to new all-time highs above $150 on vaccine optimism. However, the stock stalled there while J&J and other competitors raced to win the vaccine testing and approval race.

Johnson & Johnson shares dropped as low as $131.09 in October when the company briefly halted its COVID-19 vaccine trials after test subjects contracted unexplained illnesses.

In January 2021, the stock hit $171.50 in anticipation of the FDA approval.

While J&J didn’t win the vaccine race, its vaccine was ultimately granted emergency FDA authorization in late February 2021. Unfortunately, the FDA began limiting its recommendation of the J&J COVID-19 vaccine in May 2022 to adults ages 18 or older that cannot access vaccines produced by Pfizer Inc. (NYSE: NYSE:PFE), Moderna Inc (NASDAQ: NASDAQ:MRNA) or Novavax, Inc. (NASDAQ: NVAX). The restriction comes after reports the vaccination caused rare cases of thrombosis or thrombocytopenia syndrome (TTS).

Related Link: If You Invested $1,000 In Nikola Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now

Johnson & Johnson In 2022, Beyond: Johnson & Johnson eventually made it as high as $186.69 in April 2022 before the latest FDA ruling limiting its recommendation.

Meanwhile, Johnson & Johnson's revenue growth slowed to just 3% in the most recent quarter as investors anticipate the company's planned spinoff of its consumer health segment sometime before November 2023. Today, Johnson & Johnson shares have traded all the way back down to around $168.

Still, investors who bought Johnson & Johnson stock the day it hit its 2020 pandemic low and held on have generated some decent returns at this point. In fact, $1,000 in Johnson & Johnson stock bought on Dec. 24, 2020, would be worth about $1,604 today, assuming reinvested dividends.

Looking ahead, analysts are expecting Johnson & Johnson stock to rebound in the next 12 months. The average price target among the 18 analysts covering the stock is $187, suggesting 11.2% upside from current levels.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

If You Invested $1,000 In Johnson & Johnson Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now
 

Related Articles

Cintas Earnings, Revenue beat in Q1
Cintas Earnings, Revenue beat in Q1 By Investing.com - Sep 28, 2022

Investing.com - Cintas reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that topped expectations. Cintas announced earnings per share of...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email